Regeneron (REGN) PRALUENT Briefing Docs Positive But Risk to Labeling for Statin Intolerance, BMO Capital Says

Go back to Regeneron (REGN) PRALUENT Briefing Docs Positive But Risk to Labeling for Statin Intolerance, BMO Capital Says
Regeneron (NASDAQ: REGN) Delayed: 612.50 +2.56 (0.42%)
Previous Close $609.94    52 Week High $592.36 
Open $604.46    52 Week Low $325.35 
Day High $613.56    P/E 160.76 
Day Low $594.90    EPS $3.81 
Volume 1,604,280